Oxazolam

HCID 4617CAS 24143-17-7

기본 정보

표준 SMILES
CC1CN2CC(=O)Nc3ccc(Cl)cc3C2(c2ccccc2)O1
InChIKey
VCCZBYPHZRWKFY-UHFFFAOYSA-N
분자식
C18H17ClN2O2
평균 분자량
328.8 g/mol
단동위원소 질량
328.0978555

이름 및 식별자

우선 이름
Oxazolam
IUPAC
10-chloro-2-methyl-11b-phenyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
영어명
OXAZOLAM METHANOL SOLUTION
분자식
C18H17ClN2O2
분자량
328.79

이름 및 동의어

oxazolamOxazolazepamTranquitHializan24143-17-7Oxazolamum1V2WI2NA1CDTXSID502340110-Chloro-2-methyl-11b-phenyl-2,3,7,11b-tetrahydro(1,3)oxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one10-Chloro-2-methyl-11b-phenyl-2,3,7,11b-tetrahydro[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-oneRefChem:857082DTXCID80209312
이름 더 보기
NebusnToccataSerenal (Japanese)o-2-methyl-11b-phenyl-OXAZOLAM METHANOL SOLUTION
10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenylbenzo(6,7)(1,4)diazepino(5,4-b) oxazol-6-one13-chloro-4-methyl-2-phenyl-3-oxa-6,9-diazatricyclo(8.4.0.0^(2,6))tetradeca-1(10),11,13-trien-8-one246-032-0SerenalSerenal [Japanese]10-Chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one10-Chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-oneBenzo(6,7)-1,4-diazepino-(5,4-b)-oxazol-6-one, 10-chloro-2,3,5,6,7,11b-hexahydro-2-methyl-11b-phenyl-

데이터베이스 식별자

CAS
24143-17-7
PubChem CID
4617
DTXSID
DTXSID5023401
ChEMBL
CHEMBL2104805
ChEBI
CHEBI:31944
UNII
1V2WI2NA1C
EC Number
246-032-0
Nikkaji
J3.472J

물성

구조 계산 물성

XLogP
3
극성 표면적
41.6 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
3
회전 가능 결합 수
1
무거운 원자 수
23

실험 및 물리화학적 성질

Kovats Retention Index2564;2569;2586;2596;2590

물리화학적 성질

녹는점
187 °C · 187°C
끓는 점
495.8 · 495.8±45.0 °C(Predicted)
밀도
1.2065 · 1.2065 (rough estimate)
굴절률
1.54 · 1.5400 (estimate)
인화점
11 °C · 11 °C
저장 조건
2 · 2-8°C

안전 및 규제

GHS 분류

GHS Classification · 5건

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral];H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H331 (100%): Toxic if inhaled [Danger Acute toxicity, inhalation]

P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

유해성 정보

Regulatory InformationDEA schedule IV controlled substance
Hazard Classes and CategoriesAcute Tox. 3 (100%);Skin Irrit. 2 (100%);Eye Irrit. 2 (100%);Acute Tox. 3 (100%)

독성 정보

Treatment · 1건

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Toxicity Summary · 1건

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

규제 정보

Regulatory InformationDEA schedule IV controlled substance

안전 데이터

독성
LD50 orl-mus: 5200 mg/kg NYKZAU 66,107,70
risk_code
11-23/24/25-39/23/24/25-36/38-23/25
hazard_code
F,T
safety_code
16-36/37-45-24
DEA Controlled Substances
CSCN: 2839CSA SCH: Schedule IVNARC: No

화학 및 산업

응용 분야

용도A psychotropic agent with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a precursor to the active substance Desmethyldiazepam (D291595).

관련 반응

7건

연결된 노트

불러오는 중…